Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Clinical trial NCT04585490 · RECRUITING

Trial details

NCT number: NCT04585490
Sponsor: Maximilian Diehn
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer NSCLC, Stage III Nsclc

Start date: 2021-08-25
Primary completion: 2026-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.